What is China Regenerative Medicine International Price-to-Operating-Cash-Flow?
As of today (2025-05-31), China Regenerative Medicine International's share price is HK$0.37.
China Regenerative Medicine International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00. Hence, China Regenerative Medicine International's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for China Regenerative Medicine International's Price-to-Operating-Cash-Flow or its related term are showing as below:
HKSE:08158'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 0 Max: 6.48
Current: 6.14
During the past 13 years, China Regenerative Medicine International's highest Price-to-Operating-Cash-Flow Ratio was 6.48. The lowest was 0.00. And the median was 0.00.
China Regenerative Medicine International's Cash Flow from Operations per share for the
three
months ended in Dec. 2024 was HK$0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of China Regenerative Medicine International was 57.90% per year.
During the past 13 years, China Regenerative Medicine International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 45.00% per year. The lowest was -105.20% per year. And the median was -2.75% per year.
China Regenerative Medicine International Price-to-Operating-Cash-Flow Historical Data
The historical data trend for China Regenerative Medicine International's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Regenerative Medicine International Price-to-Operating-Cash-Flow Chart
|
China Regenerative Medicine International Annual Data
|
|
Trend |
Apr15 |
Apr16 |
Apr17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
Dec24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
- |
- |
14.47 |
4.92 |
|
China Regenerative Medicine International Quarterly Data
|
|
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Jun24 |
Dec24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
14.47 |
- |
4.92 |
Competitive Comparison of China Regenerative Medicine International's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, China Regenerative Medicine International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Regenerative Medicine International's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, China Regenerative Medicine International's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where China Regenerative Medicine International's Price-to-Operating-Cash-Flow falls into.
China Regenerative Medicine International Price-to-Operating-Cash-Flow Calculation
China Regenerative Medicine International's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.37 | / | 0 |
| = | |
China Regenerative Medicine International's Share Price of today is HK$0.37.
China Regenerative Medicine International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
China Regenerative Medicine International Business Description
Traded in Other Exchanges
N/A
Address
132 Nathan Road, Suite 2310-18, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG
China Regenerative Medicine International Ltd is an investment holding company engaged in the provision of healthcare products and services. Its reportable segments are Aesthetic medical and beauty services and Medical services. The vast majority of the company's revenue is derived from its Aesthetic medical and beauty services segment. Geographically, the People's Republic of China accounts for the majority of the revenue. It also has a presence in Hong Kong.
Executives
China Regenerative Medicine International Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:08158 has been successfully added to your